Skip to main content

Table 5 Univariate Analysis of Clinical, Pathologic and Treatment Variable for PFS in patients with osteosarcoma and high grade spindle cell sarcoma of bone

From: Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone

Characteristics

Pts n.

% 4-months PFS

95 % CI

P-value

Overall

 

46

46

31–61

 

Age

 ≥18 years

23

65

43–88

0.4

 <18 years

23

35

17–53

 

Sex

 Female

12

50

22–78

0.7

 Male

34

44

27–62

 

Mets Site

 Lung only

24

61

41–81

0.1

 Multiple

22

30

11–50

 

Line GD

 2

13

60

32–87

0.4

 ≥3

33

41

24.58

 

ECOG

 0

29

54

35–72

0.003

 1

13

43

15–71

 

 2

4

0

0

 

Histology

 Osteosarcoma

35

56

39–73

0.005

 HGS

11

18

0–41

 
  1. PFS Progression Free Survival, HGS high grade spindle cell sarcoma of bone, GD gemcitabine and docetaxel
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us